SCHEMBL3085333

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL3077431	0.90	AR (0.45)	ARNSD2SLC22A12
	SCHEMBL3070135	0.89	HTT (0.46)	ARPOLBHTTL3MBTL1
	SCHEMBL3079008	0.86	AR (0.47)	ARPOLBNSD2SLC22A12TSHR
	SCHEMBL3070091	0.86	AR (0.47)	ARPOLBNSD2TSHRHTT
	SCHEMBL3081229	0.86	AR (0.50)	ARPOLBNSD2TSHR
	SCHEMBL3081186	0.85	AR (0.43)	ARNSD2
	SCHEMBL3086046	0.85	AR (0.46)	ARPOLBNSD2TSHREGLN2
	SCHEMBL3086188	0.84	AR (0.53)	ARNSD2TSHRHTT
	SCHEMBL3082039	0.84	AR (0.47)	ARNSD2
	SCHEMBL3074104	0.83	AR (0.50)	ARPOLBSLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.